# DESCRIPTION

## BACKGROUND OF THE INVENTION

## SUMMARY OF THE INVENTION

## DETAILED DESCRIPTION OF THE INVENTION

### I. Definitions

### II. Tumor Associated Antigens

### III. Recombinant Viral Vectors

### IV. Pharmaceutical Composition

### V. Combination with Checkpoint Inhibitors and Chemotherapy

### VI. Method of Use

## EXAMPLES

### Example 1. MVA Vaccine Vectors

### Example 2. Sequence Optimization

### Example 3: MVA Vaccine Construction and In Vitro Evaluation for Hypoglycosylated Forms of MUC1

### Example 4: Targeted Diminution of O-Linked Glycosylation of Muc1

